Causes of Secondary and Prolonged Fever During Treatment of Bacterial Meningitis and Viral Encephalitis
Launched by ASSIUT UNIVERSITY · May 10, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying why some children develop a fever that lasts longer than expected during treatment for bacterial meningitis or viral encephalitis. Meningitis is an infection of the protective membranes covering the brain and spinal cord, while encephalitis is swelling of the brain. The researchers want to understand the causes of these fevers in children aged one month to 18 years who are receiving treatment at Assiut University Children's Hospital.
To join the study, children must have been diagnosed with either bacterial meningitis or viral encephalitis and be admitted to the hospital. They should also have a fever that persists despite receiving the right treatment. However, children with certain health conditions, such as autoimmune diseases or those on medications that weaken their immune system, will not be included. Participants in the trial will help doctors learn more about these fevers, which may lead to better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children from one month to 18 years.
- • Who were diagnosed with bacterial meningitis or viral encephalitis and admitted to neurological department at Assiut University Children's Hospital (AUCH).
- • Develop secondary or prolonged fever despite appropriate treatment.
- Exclusion Criteria:
- • Pediatric patients with suspected autoimmune encephalitis.
- • Patient on immunosuppressive therapy (e.g., post-organ transplant, chemotherapy).
- • Pediatric patients suspected metabolic disorders.
- • Those with suspected endocrine dysfunction.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Prof. Mostafa Shafeek Khalaf Tawfeek, Professor of Pediatrics
Principal Investigator
Assiut University
Dr. Khalaf Abd El-Aal Sayed Mohamed, Lecturer of Pediatrics
Principal Investigator
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported